Hyperbaric oxygen therapy for postoperative ischemic bronchitis after resection of lung cancer | Canada Hyperbarics Skip to main content
Study J Thorac Dis 2018

Hyperbaric oxygen therapy for postoperative ischemic bronchitis after resection of lung cancer

Endoh M, Oizumi H, Kato H, Suzuki J, Watarai H, Hamada A, et al. — J Thorac Dis, 2018

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers retrospectively examined how hyperbaric oxygen therapy (HBOT) affected postoperative ischemic bronchitis (POIB) in patients who had undergone lung cancer surgery.

What They Found

The study identified 7 male patients, median age 65, who received HBOT for POIB after lung cancer surgery. HBOT involved daily 60-minute sessions at 2.0 absolute atmospheres with 100% oxygen for a median of 7 days. POIB resolved in 5 of these patients, while it worsened in 2, requiring additional surgery.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This study was limited by its retrospective design and the very small number of patients included.

Was this summary helpful?

Study Details

Study Type Study
Category Uncategorised
Source Pubmed
PubMed ID 30622789
Year Published 2018
Journal J Thorac Dis

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.